Zynerba Pharmaceuticals, Inc. (ZYNE) has 43 open-market insider trades by 15 insiders since 2015. The most active filer is Michael Rapp, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Michael Rapp | 10% Owner | — | 6 | $2.4M | 2018-05-30 |
| James E. Fickenscher | CFO | — | 6 | $333K | 2023-10-10 |
| Armando Anido | Chairman | — | 5 | $246K | 2023-10-10 |
| Thomas L. Harrison | Dir | — | 1 | $175K | 2015-08-10 |
| Suzanne M. Hanlon | CLOVPSecretary | — | 3 | $161K | 2021-01-21 |
| Terri B. Sebree | Pres | — | 4 | $62K | 2023-10-10 |
| John P. Butler | Dir | — | 3 | $32K | 2023-10-10 |
| Brian Rosenberger | VPCommercial & Business Dev. | — | 3 | $21K | 2023-10-10 |
| Kenneth T. Jones | — | — | 1 | $3K | 2023-10-10 |
| Albert P. Parker | CLO | — | 1 | $2K | 2023-10-10 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Armando Anido | Chairman | Sell | $24K | 2023-09-13 |
| Terri B. Sebree | President | Sell | $16K | 2023-09-13 |
| Brian Rosenberger | VP & Commercial & Business Dev. | Sell | $9K | 2023-09-13 |
| Kenneth T. Jones | — | Sell | $3K | 2023-09-13 |
| James E. Fickenscher | CFO | Sell | $12K | 2023-09-13 |
| Pamela Stephenson | Director | Sell | $40 |
Companies that share insiders with ZYNE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-06-14 |
| Albert P. Parker | CLO | Sell | $2K | 2023-02-15 |
| James E. Fickenscher | CFO | Sell | $11K | 2023-01-23 |
| Brian Rosenberger | VP & Commercial & Business Dev. | Sell | $8K | 2023-01-23 |
| Terri B. Sebree | President | Sell | $15K | 2023-01-23 |
| Armando Anido | Chairman | Sell | $21K | 2023-01-23 |
| Brian Rosenberger | VP & Commercial & Business Dev. | Sell | $5K | 2022-07-19 |
| Armando Anido | Chairman | Sell | $13K | 2022-07-19 |
| James E. Fickenscher | CFO | Sell | $7K | 2022-07-19 |
| Terri B. Sebree | President | Sell | $9K | 2022-07-19 |